What the Agelity® brain health review covers
This peer-reviewed narrative review, published in Neural Regeneration Research, provides an integrated scientific analysis of the relationship between brain insulin signaling, related cellular pathways, and cognitive aging. The article positions Agelity®, Advenion Nutrition’s standardized D-Pinitol ingredient, as a key inositol-derived metabolic modulator of relevance to brain metabolic health.
The review discusses how Agelity® may support insulin signaling through the PI3K/Akt pathway, help maintain balanced CDK5-related signaling, and contribute antioxidant support relevant to brain health during aging. By connecting metabolic balance with brain function, this publication outlines a conceptual and mechanistic framework for Agelity® as a nutrient-based approach to support healthy brain insulin signaling and cognitive aging. By framing the specific Agelity® ingreKnowledge Hubdient within the broader science of inositol metabolism, the review reinforces the value of standardization and analytical control.
This article is a scientific review intended for scientific and product-development audiences. These statements have not been evaluated by the Food and Drug Administration. Agelity® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease, including Alzheimer’s disease.